𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BRAF inhibitor activity in V600R metastatic melanoma

✍ Scribed by Klein, Oliver; Clements, Arthur; Menzies, Alexander M.; O’Toole, Sandra; Kefford, Richard F.; Long, Georgina V.

Book ID
120155470
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
793 KB
Volume
49
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined BRAF and MEK Inhibition in Mela
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
✍ Flaherty, Keith T.; Infante, Jeffery R.; Daud, Adil; Gonzalez, Rene; Kefford, Ri 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 528 KB

## Background Resistance to therapy with BRAF kinase inhibitors is associated with reactivation of the mitogen-activated protein kinase (MAPK) pathway. To address this problem, we conducted a phase 1 and 2 trial of combined treatment with da braf e nib, a selective BRAF inhibitor, and trametinib, a

The role of BRAF V600 mutation in melano
The role of BRAF V600 mutation in melanoma
✍ Paolo A Ascierto, John M Kirkwood, Jean-Jacques Grob, Ester Simeone, Antonio M G 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 261 KB